New multicenter data presented at AAPM 2026 strengthen the evidence for molecular breast imaging as a supplemental screening tool in women with dense breasts.
This website uses cookies to give our readers the best website experience. Please refer to our privacy policy to find out how we use cookies and how you can edit your preferences.
